In this study we plan to determine why histone mutations are associated with pathogenesis of childhood brain tumors and how we can take advantage of such information for the development of targeted therapeutics of this form of childhood brain cancer.
|Effective start/end date||1/1/16 → 12/31/19|
- Ann & Robert H. Lurie Children’s Hospital of Chicago (Agreement 08/28/17 // Agreement 08/28/17)
- John McNicholas Pediatric Brain Tumor Foundation (Agreement 08/28/17 // Agreement 08/28/17)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.